warnings
WARNINGS Avoid contact with eyes, lips and mucous membranes.
Urea 41%
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Urea 41%
- Generic name
- UREA
- Manufacturer
- Oncora Pharma, LLC
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- 37576876-738c-ac79-e063-6394a90a84fe
- SPL ID
- 37576876-738d-ac79-e063-6394a90a84fe
- Version
- 1
- Effective date
- 2025-06-11
- Source export date
- 2026-09-28
- Source partition
- 9
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/6784607726c827491ceaeab30d843632e0660ee8008c535197be5ed9e1e52201/drug-label-0009-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 06:04:48
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | Urea 41% | openfda.brand_name | |
| generic name | UREA | openfda.generic_name | |
| manufacturer name | Oncora Pharma, LLC | openfda.manufacturer_name | |
| ndc | package | 85477-905-30 | openfda.package_ndc |
| ndc | product | 85477-905 | openfda.product_ndc |
| ndc11 | package | 85477090530 | derived:openfda.package_ndc |
| rxcui | 1436933 | openfda.rxcui | |
| spl id | 37576876-738d-ac79-e063-6394a90a84fe | id | |
| spl set id | 37576876-738c-ac79-e063-6394a90a84fe | set_id | |
| unii | 8W8T17847W | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS: Discontinue use and consult a physician if redness or irritation occurs.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.